Rebalix
Franklin Templeton · sheet of 10 September 2026
Franklin Templeton · sheet of 10 September 2026ETF sheet · official issuer and register data
Franklin S&P 500 Paris Aligned Climate UCITS ETF
USPA · IE00BMDPBZ72 · class SINGLCLASS · USD · domicile Ireland
Equity · United States · Large cap · Sustainable / ESGSFDR art. 8
Index tracked: S&P 500 PAB ESG Index-NR
- TER
- 0.07%+ trans. 0.14%
- Fund size
- 301 m EUR
- Tracking difference
- +0.13%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical (full replication)
- Income
- Accumulating
Launch 29 Jul 2020 · costs from the KID as of 2 Sept 2026 · 223 securities held · 10 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Sept 2026
Investment Objective To provide exposure to large capitalisation US stocks which are aligned to the transition to a low carbon economy.
Investment Policy
The Fund invests in equities of US companies of large market capitalisation that transition to a lower carbon economy or are less exposed to climate transition risks. These investments are included in the benchmark. The benchmark is based on the S&P 500 Index, its parent index, and provides exposure to US large capitalisation securities which are better aligned with the move towards a low-carbon…
Performance since series start (in euro) — base 100
31 Jul 2020 → 31 Jul 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +20.5% |
| 3 years | +58.8% |
| 5 years | +85.3% |
| 10 years | series too young |
| Since series start | +149.4% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 12.91% | 14.86% | 17.33% |
| Max drawdown | −11.17% | −18.83% | −28.05% |
| Sharpe | 1.10 | 1.08 | 0.56 |
| Sortino | 1.59 | 1.60 | 0.81 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · USPA · IE00BMDPBZ721
RebalixUSPA · IE00BMDPBZ72 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +15.80% | +15.66% | +0.13% |
| 2024 | +26.21% | +26.09% | +0.12% |
| 2023 | +29.75% | +29.62% | +0.13% |
| 2022 | −21.81% | −21.95% | +0.14% |
| 2021 | +31.16% | +31.11% | +0.05% |
Holdings
Portfolio as declared by the issuer · 26 Aug 2026 · 223 securities · top-10 weight = 38.8%
| Top holdings | Weight |
|---|---|
| 8.4% | |
| 5.8% | |
| 5.0% | |
| 3.3% | |
| 3.2% | |
| 3.0% | |
| 2.8% | |
| 2.6% | |
| 2.4% | |
| 2.4% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
USPA · Borsa Italiana (ETFplus), Euronext Amsterdam
FLX5 · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 16 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BMDPBZ72
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BMDPBZ72
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · USPA · IE00BMDPBZ722